Trial Profile
Clinical Study to Evaluate the Efficacy, Pharmacokinetics and Safety of Immunoglobulin Intravenous (Human) 10% (NewGam) in Patients With Primary Immunodeficiency Diseases
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 20 Mar 2017
Price :
$35
*
At a glance
- Drugs Immunoglobulin G (Primary)
- Indications Immunodeficiency disorders
- Focus Therapeutic Use
- Sponsors Octapharma
- 08 Aug 2014 New trial record